ITGAM and B-cell chronic lymphocytic leukemia: Second, the SCI+CLL group showed a significantly lower percentage of infiltrating MDMs (CD11b+CD45hi) than that of the SCI group (6.01±1.28% versus 16.58±10.11% at dpi-3, P<0.05; Fig. 5D,E).